EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Pristimerin Attenuates Fibrogenesis and Inflammation Through TIPE1 ‐Regulated P2X7r Inflammatory Signaling Cascades in Hepatic Fibrosis

Guan-Cheng Liu iD, Qi-Yuan Feng, Shuya Li, Yue Shang iD, Xin Guo, Hai-Ming Sun, Yu-Chen Jiang, Jian Song iD

Phytotherapy Research · 2026-11-11

DOI: 10.1002/ptr.70502 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-11-11. Written by Guan-Cheng Liu and 7 co-authors. Institution: College of Pharmacy, Beihua University, Jilin, Jilin Province, China. 41 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Scientific and Technological Developing Scheme of Jilin Province of People's Republic of China, Education Department of Jilin Province, the Scientific Research Startup Foundation for Doctors of Beihua University.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Pristimerin (Pris), a natural triterpenoid extracted from Celastrus orbiculatus Thunb. and Gymnosporia acuminata Hook. f., has various pharmacological activities, including anti‐inflammatory and anti‐tumor effects. Our study explored the influence of Pris on fibrogenesis and inflammatory modulation via the tumor necrosis factor‐alpha‐induced protein 8‐like 1 (TIPE1)‐P2X7r axis in hepatic fibrosis. We induced a model of hepatic fibrosis in mice through intraperitoneal administration of Thioacetamide (TAA). To elucidate the pathways associated with fibrosis, RNA sequencing was performed. HSC‐T6 cells were stimulated with transforming growth factor‐β (TGF‐β) while LX‐2 cells were treated with siRNA targeting TIPE1. Bone marrow‐derived macrophages (BMDMs) were exposed to a combination of lipopolysaccharide and adenosine triphosphate (LPS/ATP) along with Pris to produce conditioned medium. RNA sequencing data indicated significant alterations in pathways involving TIPE1, NOD‐like receptors, and neutrophil extracellular traps (NETs) in the fibrosis context. Pris decreased accumulation of extracellular matrix (ECM) and the epithelial‐mesenchymal transition (EMT) in the fibrotic liver. Pris significantly reduced the secretion of inflammatory mediators, NETs, and fibrosis markers. Pris activated TIPE1 while suppressing P2X7r and NLRP3 (NOD‐like receptor family pyrin domain‐containing protein 3) expression in activated HSCs and in TAA‐challenged mice. Furthermore, Pris diminished ECM expression and reversed macrophage‐induced activation of HSCs, supporting previous findings. The absence of TIPE1 impaired Pris's ability to inhibit P2X7r in LX‐2 cells. Additionally, while LPS/ATP stimulation upregulates NLRP3, GSDMD, and IL‐23 in mouse BMDMs, Pris exerts a notable inhibitory effect on these pyroptosis factors. Thus, our study demonstrates that Pris alleviates hepatic fibrosis by regulating the TIPE1‐P2X7r axis. This finding not only positions Pris as a promising therapeutic candidate but, more importantly, highlights the critical role of the TIPE1‐P2X7r axis in hepatic fibrosis, integrating purinergic P2X7r signaling, NLRP3 inflammasome activation, macrophage‐HSC crosstalk, and NETs formation into an integrated mechanistic network.

Subjects

Author keywords

P2X7rPristimerinTIPE1hepatic fibrosisinflammatory reactions

Authors and institutions

  • College of Pharmacy, Beihua University, Jilin, Jilin Province, China.
  • Department of Pharmacy, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
  • School of Pharmacy and Medicine, Tonghua Normal University, Tonghua, Jilin Province, China.

ORCID profiles: Guan-Cheng Liu, Yue Shang, Jian Song

Funding

  • Scientific and Technological Developing Scheme of Jilin Province of People's Republic of China
  • Education Department of Jilin Province
  • the Scientific Research Startup Foundation for Doctors of Beihua University

Cite

APA

Liu, G. C., Feng, Q. Y., Li, S., Shang, Y., Guo, X., Sun, H. M., Jiang, Y. C., & Song, J. (2026). Pristimerin Attenuates Fibrogenesis and Inflammation Through TIPE1 ‐Regulated P2X7r Inflammatory Signaling Cascades in Hepatic Fibrosis. Phytotherapy Research. https://doi.org/10.1002/ptr.70502

Vancouver

Liu GC, Feng QY, Li S, Shang Y, Guo X, Sun HM, et al. Pristimerin Attenuates Fibrogenesis and Inflammation Through TIPE1 ‐Regulated P2X7r Inflammatory Signaling Cascades in Hepatic Fibrosis. Phytotherapy Research. 2026. doi:10.1002/ptr.70502

BibTeX
@article{Liu2026,
  author = {Liu, Guan-Cheng and Feng, Qi-Yuan and Li, Shuya and Shang, Yue and Guo, Xin and Sun, Hai-Ming and Jiang, Yu-Chen and Song, Jian},
  title = {Pristimerin Attenuates Fibrogenesis and Inflammation Through TIPE1 ‐Regulated P2X7r Inflammatory Signaling Cascades in Hepatic Fibrosis},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70502}
}
Start for free →